منابع مشابه
Anaemia of CKD—the CHOIR study revisitedy
Anaemia is a common complication of kidney disease and is treated with erythropoietin. However, the optimal target haemoglobin (Hb) in treating CKD anaemia has become quite controversial. There have been several randomized controlled studies of erythropoietin among kidney patients published over the past several years. The Normal Hematocrit study (NHS), a study of high-risk dialysis patients [1...
متن کاملCorrection: A 3-Marker Index Improves the Identification of Iron Disorders in CKD Anaemia
BACKGROUND Iron disorders are common and complex in chronic kidney disease (CKD). We sought to determine whether a 3-marker index would improve the classification of iron disorders in CKD anaemia. METHODS We studied the association between Hb level and iron indexes combining 2 or 3 of the following markers: serum ferritin (<40 ng/mL), transferrin saturation (TSAT<20%) and total iron binding c...
متن کاملOPTA: Optimal treatment of anaemia in patients with chronic kidney disease (CKD)
In the early stages of CKD, anaemia is nonsymptomatic. Patients adapt to a certain level and to further declining haemoglobin (Hb) levels. The fact that modest decrements in renal function already lead to a decrease in Hb levels is underestimated, especially outside the nephrology field, e.g. patients with diabetes [1]. In many European countries, patients with CKD are managed by non-nephrologi...
متن کاملKey insights into present and future treatments of anaemia in CKD patients
The introduction of erythropoiesis-stimulating agents (ESAs) revolutionized the management of anaemia in chronic kidney disease (CKD) patients by providing effective control of haemoglobin (Hb) levels, reducing the need for blood transfusions and improving patient quality of life. The use of ESAs in CKD patients is constantly evolving as new research helps us to better understand how to safely ...
متن کاملCorrection of iron deficiency anaemia using IV CosmoFer in CKD patients with asthma: a prospective study.
BACKGROUND Intravenous (IV) iron is commonly used for correcting iron deficiency anaemia in patients with chronic kidney disease (CKD). There remains a concern for its use in patients with asthma as it may trigger an acute exacerbation. Pre-treatment with a single dose of parenteral hydrocortisone may obviate this risk. METHOD We carried out a prospective study of known asthmatic patients wit...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 2013
ISSN: 0931-0509,1460-2385
DOI: 10.1093/ndt/gft131